This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
This is a firm fixed price delivery order contract awarded to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, to provide a support plan for an Illumina MiSeq sequencing instrument. The $15,145.13 contract was awarded by the Plains Area division of an unnamed civilian federal agency. Illumina has previously provided a range of sequencing systems and related goods and services to support research and diagnostics at agencies like the NIH, CDC, USDA, and...
This is a firm fixed-price delivery order awarded by the Animal and Plant Health Inspection Service, a civilian agency within the U.S. Department of Agriculture, to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The $14,562.62 award is for the renewal of a service contract to provide maintenance and support for Illumina's MiSeq sequencing equipment. The order has a period of performance through July 29, 2024 and does not include any set-aside...
This is a $15,849.80 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the maintenance of a MiSeq M06580 DNA sequencing instrument and associated services. The contract has a period of performance through September 11, 2026. Illumina, a manufacturer of genomic sequencing technologies, has been awarded multiple federal contracts and grants by the NIH, Centers...
This is a firm fixed price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for annual support and maintenance services for the agency's MISEQ sequencing instruments. The contract has a ceiling value of $89,504.00 and a completion date of October 27, 2029. The award does not mention any set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has received previous prime and subcontract awards...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on Illumina's MiSeq benchtop DNA sequencing instruments. The contract has a ceiling value of $225,606.45 and runs through December 5, 2017. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has provided these types of goods and services to support research and diagnostic programs across various...
This federal contract award, valued at $14,562.64, was issued by the Southeast Area of the Department of Defense to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The one-year contract provides for annual preventative maintenance services on Illumina's MiSeq sequencing system. The contract does not have a set-aside designation and is a firm fixed price delivery order. Illumina has previously provided sequencing systems, reagents, and services to...
This firm fixed-price purchase order was awarded by the U.S. Secret Service, a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $80,727.00, is for the maintenance of an Illumina MiSeq sequencing system. The performance period extends through April 24, 2025. This award is not associated with a set-aside designation. Illumina has been awarded numerous prime federal contracts and grants to provide...
This firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for preventative maintenance on a MiSeq benchtop sequencer, with a potential value of $26,157.45 and a completion date of September 29, 2018. Illumina has a history of providing sequencing systems and related products and services to support genomic research and diagnostics at...